1

ECAS 2019 ADVANCE SCIENTIFIC PROGRAM

SUNDAY JUNE 16, 20198:30 AM - 10:00 AMROOM GRAND LARGEWorkshop WS-01

Atrial fibrillation ablation in 2020

Chairpersons: Douglas Packer (Rochester, USA), Mahmoud Suleiman (Haïfa, IL)

1. Is there a mortality benefit with AF ablation in CABANA : Impact of normal si-nus rhythm

Douglas Packer (Rochester, USA)

2. Dealing with CHF with AF : Biventricular pacing or AF ablation Hugh Calkins (Baltimore, USA)

3. Revisiting mode of AF ablation : linear and rotor ablationDavid Wilber (Chicago, USA)

4. AF ablation – endpoint of AF ablation : 30 sec vs monitoringJeanne Poole (Seattle, USA)

SUNDAY JUNE 16, 20198:30 AM - 10:00 AMROOM ESTAQUEWorkshop WS-02

Prevention and management of device infections

Chairpersons: Bruce Wilkoff (Cleveland, USA), Christoph Starck (Berlin, DE)

1. Pathophysiology and bacteriology of CIED infectionsRizwan M Sohail (Rochester, USA)

2. Impact of CIED Infections on survivalBruce Wilkoff (Cleveland, USA)

3. Prophylactic and peri procedural antibiotics before and after the PADIT trialJamil Bashir (Vancouver, CA)

4. Antibiotic envelope therapy before and after WRAP-IT Charles Kennergren (Gothenburg, Sweden)

Panel discussion: What is and should be the rate of CIED Infection and what are the barriers to optimal infection prevention?

2

SUNDAY JUNE 16, 20198:30 AM - 10:00 AMROOM JOLIETTEWorkshop WS-03

ECG pacemaker and CRT dysfunction (case studies)

Chairpersons: Eli Ovsyshcher (Beersheba, IL)

1. Bengt Herweg (Tampa, USA)

2. Promund Obel (Johannesburg, ZA)

3. Pugazhendhi Vijayaraman (Wilkes Barre, USA)

4. Brian Olshansky (Iowa City, USA)

SUNDAY JUNE 16, 20198:30 AM - 10:00 AM ROOM SAINT JEANWorkshop WS-04

A mandatory issue: anatomical knowledge for catheter ablation targets

Chairpersons: Roger Winkle (Palo Alto, USA), Mohammad Shenasa (San Jose, USA)

1. AVNRT and accessory pathway ablationCarlo Lavalle (Rome, IT)

2. Atrial flutter ablation John Catanzaro (Jacksonville, USA)

3. Atrial fibrillation ablationLuigi Di Biase (New York, USA)

4. Ventricular Tachycardia ablationRichard Schilling (London, GB)

SUNDAY JUNE 16, 20198:30 AM - 10:00 AMROOM MUCEMWorkshop WS-05

Syncope and tachycardias related to autonomous nervous system disturbances

Chairpersons: David Benditt (Minneapolis, USA), Richard Sutton (Monaco, MC)

3

1. Postural orthostatic tachycardia syndrome (POTS)David Benditt (Minneapolis, USA)

2. Effect of AF on the autonomous nervous system and cognitive impairmentLena Rivard (Montreal, CA)

3. Syncope in competitive athletesAntonio Raviele (Venice, IT) NOT COMING

4. Inappropriate sinus tachycardia: a diagnosis of eliminationSamuel Levy (Marseille, FR)

SUNDAY JUNE 16, 20198:30 AM - 10:00 AMROOM NOTRE DAMEWorkshop WS-06

Case-based presentation of EP tracings dedicated to young electrophysiologists

Chairpersons: Roberto De Ponti (Varese, IT), Albert Waldo (Cleveland, USA)

1. Various clinical aspects of atrial flutter Albert Waldo (Cleveland, USA)

2. Tracings of arrhythmias involving the atrioventricular junction Jacopo Marazzato (Varese, IT)

3. Tracings of arrhythmias involving atrioventricular accessory pathwaysWarren Jackman (Oklahoma City, USA)

4. Tracings of ventricular arrhythmias Roland Tilz (Luebeck, DE)

Sunday JUNE 16, 201912:15 pm-1:45 pm Room EUGENIE

Luncheon Panel

SUNDAY JUNE 16, 2019 2:00 PM - 3:30 PM

4

ROOM GRAND LARGESession SP-01

12th　 Japan HRS-ECAS (DRAFT)Program coordinators: Samuel Levy (ECAS) and Yuji Nakazato (JHRS) Cardiac arrhythmia ablation: Learning from difficult cases

Chairpersons: Kenzo Hirao (Tokyo, JP), Yuji Nakazato (Tokyo, JP)

1. Atypical flutter ablationDipen Shah (Geneva, CH）

2. Atrial fibrillation ablationKazuhiro Satomi （Tokyo, JP）

3. PVC ablation Joel Fedida (Paris, FR)

4. VT/VF ablationAkihiko Nogami (Tsukuba, JP)

SUNDAY JUNE 16, 20192:00 PM - 3:30 PMROOM ESTAQUESession AF-01

New insights into mechanisms and pathogenesis of atrial fibrillation (AF)

Chairpersons : Albert Waldo (Cleveland, USA), Reza Wakili (Essen, DE)

1. Fat and AF Stephane Hatem (Paris, FR)

2. Obstructive sleep apnea and AF ablationMahmoud Suleiman (Haïfa, IL)

3. Ventricular fibrosis and AF Fu Siong Ng (London, GB)

4. Inflammatory signaling and AF Dobromir Dobrev, (Essen, DE)

SUNDAY JUNE 16, 20192:00 PM - 3:30 PMROOM JOLIETTESession SP-02

5

Aggressive ablation for ventricular tachycardia?

Chairpersons: Richard Schilling (London, GB), Douglas Packer (Rochester, USA)

1. Best ablative guides for ARVC, sarcoid, myocarditis, and other offbeat ventricular tachycardiasDavid Wilber (Chicago, USA)

2. Role of intracardiac ultrasound in guided VT ablation: from PVCs to ICE-guided structural interventionsJared Thomas Bench (Philadelphia, USA)

3. Recent Clinical outcomes of advanced VT ablation: “Photon vs. particle therapy”?Phillip S. Cuculich (Saint Louis, USA)

4. Potential effect of VT ablation on mortalityKarl-Heinz Kuck (Hamburg, DE)

SUNDAY JUNE 16, 20192:00 PM - 3:30 PM ROOM SAINT JEANSession SP-03

Cardiovascular complications of energy drinks

Chairpersons: Samuel Levy (Marseille, FR), Antonio Raviele (Venice, IT)

1. Composition of commercially available energy drinksLuca Santini (Rome, IT)

2. Reports of cardiovascular complications of energy drinksAli Oto (Ankara, TR)

3. Role of caffeine and other ingredients contained in energy drinksAlessandro Capucci (Ancona, IT)

4. ECAS recommendation statement Maurizio Santomauro and Carla Riganti (Naples, IT)

SUNDAY JUNE 16, 20192:00 PM - 3:30 PMROOM MUCEMSession SP-04

Septal accessory pathways: diagnosis, localization and catheter ablation(Interactive case discussions)

6

Session proposed and conducted by Jasbir Sra (Milwaukee, USA), Warren Jackman (Milwaukee and Oklahoma City, USA) and Stavros Stavrakis (Oklahoma City, USA)

1. Anteroseptal pathway-interactive case discussion

2. Left vs right mid septal pathway-interactive case discussion

3. Postero-septal vs accessory pathway from the middle cardiac vein: interactive case discussion

4. Discussion with audience participation

SUNDAY JUNE 16, 20192:00 PM - 3:30 PMROOM NOTRE DAMESession SP-05

Management of lead extraction patients

Chairpersons: Charles Kennergren (Gothenburg, SE), Eli Ovsyshcher (Beersheba, IL)

1. Preoperative imaging for transvenous lead extractionDonald Hegland (Durham, USA)

2. Intraoperative imaging for transvenous lead extractionHemal Nayak (Chicago, USA)

3. Prepping and protection during vascular emergencies Bruce Wilkoff (Cleveland, USA)

4. Surgical rescue for SVC and other vascular emergencies Jamil Bashir (Vancouver, CA)

3:30 PM - 4:00 PM Coffee break and visit to posters

SUNDAY JUNE 16, 2019 4:00 PM - 5:30 PMROOM GRAND LARGESession SP-06

Anticoagulation using DOACs in atrial fibrillation: what is new ?Supported by an educational grant from Bayer AG

Chairs: Thomas Deering (Atlanta, USA), Christine Albert (Boston, USA)

1. CardioversionEugene Crystal (Toronto, CA)

2. AF AblationLuigi Di Biase (New-York, USA)

7

3. Direct oral anticoagulants in patients with renal impairment Hendrik Bonnemeier (Kiel, DE)

4. Advances and limitations in the real wordThomas Deering (Atlanta, USA)

5. AF DOAC ControversiesAndrea Russo (Camden, USA)

SUNDAY JUNE 16, 2019 4:00 PM - 5:30 PMROOM ESTAQUESession AF-02Trials and meta-analyses in atrial fibrillation and their impact on current practice

Chairpersons: Riccardo Cappato (Milan, IT), Antony Chu (Providence, USA)

1. Interpretation of the CABANA Trial resultsDouglas L Packer (Rochester, USA)

2. Interpretation of the CASTLE Trial results Johannes Brachmann (Coburg, DE)

3. Targeting ganglion plexi in AF ablation with and without PV isolationSunny Po (Oklahoma City, USA)

4. Targeting complex electrograms with and without PV isolation Julien Seitz (Marseille, FR)

SUNDAY JUNE 16, 20194:00 PM - 5:30 PMROOM JOLIETTESession SD-01

How to optimize pulmonary vein isolation?

Chairpersons: Ellen Hoffmann (Munich, DE), David Haines (Royal Oak, USA)

1. 20 years of pulmonary vein isolation – Contemporary outcomesKenzo Hirao (Tokyo, JP)

2. Strategies to optimize PVI using radiofrequency energyDavid Haines (Royal Oak, USA)

3. Strategies to optimize PVI using cryoablationFlorian Straube (Munich, DE)

4. Role of contact forceRoberto De Ponti (Varese, IT)

8

5. Additional sites beyond the pulmonary veinsLi-Wei Lo (Taipei, TW)

SUNDAY JUNE 16, 20194:00 PM - 5:30 PM ROOM SAINT JEANSession SP-07

ECG interpretation course (Part 1: conduction disturbances)A tribute to Agustin Castellanos Jr (1927-2017)

Chairpersons: Sanjeev Saksena (Warren, USA), Mark Estes III (Boston, USA)

1. The Bayes syndrome Antoni Bayes de Luna (Barcelona, ES)

2. What is new in congenital AV block management? George van Hare (St Louis, USA)

3. Conduction abnormalities complicating acute myocardial infarctionSamuel Lévy (Marseille, FR)

4. ECG of bradyarrhythmiasBengt Herweg (Tampa, USA)

SUNDAY JUNE 16, 20194:00 PM - 5:30 PMROOM MUCEMSession SP-08

Challenges in clinical care of patients with the dysautonomic syndromes

Chairpersons: David Benditt (Minneapolis, USA), David Cannom (Los Angeles, USA)

1. Clinical characteristics that assure the diagnosis of POTS and misleading symptoms

Brian Olshansky (Iowa, USA)

2. Role of autoimmune disorders and mast cell diseases in dysautonomic syndromes

David Benditt (Minneapolis, USA)

3. Role of clinical laboratory testing for the differential diagnosis of dysautonomic syndromes

Gert van Dijk, (Leiden, NL)

4. Impact of education and support in the care of patients with dysautonomic syndromes?

9

Richard Sutton (Monaco, MC).

SUNDAY JUNE 16, 20194:00 PM - 5:30 PMROOM NOTRE DAMESession SP-09

Complications during electrophysiological procedures

Chairpersons: Dipen Shah (Geneva, CH), Prapa Kanagaratnam (London, GB)

1. Complications of catheter ablation of atrial fibrillation and flutter in GermanyGerhard Steinbeck (Munich, DE)

2. Arrhythmic emergencyStephanie Fichtner (Munich, DE)

3. Pericardial tamponadeNoel Boyle (Los Angeles, USA)

4. Thermic esophagus damageThomas Deneke (Bad Neustadt, DE)

5. My worst nightmareRichard Schilling (London, GB)

Room EUGENIE5:30 PM to 6:00 PM

Philippe Coumel Special lecture:

By

Opening ceremony

Outstanding Achievement Awards

Followed by a cocktail Reception

MONDAY JUNE 17, 2019 8:30 AM - 10:00 AMROOM GRAND LARGESession SD-02

Prevention of sudden cardiac death (SCD) in young adults

Chairpersons: Mark N. Estes III (Pittsburgh, USA), Xavier Jouven (Paris, FR)

1. Physiopathology of SCD

10

Munther K. Homoud (Boston, USA)

2. Risk stratification of SCD in young adults: Have we progressed?Domenico Corrado (Padua, IT)

3. Sudden cardiac death during sports activitiesEloi Marijon (Paris, FR)

4. Autopsy as a tool in the prevention of sudden death in the youngAudrey Farrugia-Jacamon (Strasbourg, FR)

MONDAY JUNE 17, 20198:30 AM - 10:00 AMROOM ESTAQUESession AF-03

Ablation for atrial fibrillation (AF): clinical challenges and new frontiers Chairpersons:  Luc Jordaens (Brussels, BE), Neil Sulke (Eastbourne, GB)

1. Challenges in persistent AF ablation: Targets beyond the PVs Walid Saliba (Cleveland, USA)

2. Treatment strategies post CABANA: Did we miss the real questions in AF care? Ayman Hussein (Cleveland, USA)

3. Simultaneous LAA occlusion and atrial fibrillation ablation: is it a risk or a benefit? Lucas Boersma (Amsterdam, NL)

4. Anticoagulation cessation after successful ablation: Should we do it? Antony Chu (New-York, USA)

MONDAY JUNE 17, 20198:30 AM - 10:00 AM ROOM JOLIETTESession SP-10

New guidelines in arrhythmia management: How should these change patient care?

Chairpersons: John Camm (London, GB), Robert Hauser (Minneapolis, USA)

1. Ventricular arrhythmia and sudden death prevention: Are we saving lives? Christine Albert (Boston, USA)

11

2. Catheter and surgical ablation for AF: Where are we in 2018? Hugh Calkins (Baltimore, USA)

3. Bradycardia and device management: How do the new guidelines Impact patient care? Massimo Santini (Rome, IT)

4. Can patients with a non-MRI conditional device undergo a safe MRI? Julia Indik (Tucson, USA)

MONDAY JUNE 17, 20198:30 AM - 10:00 AMROOM SAINT JEANSession WS-07

Risk of sudden cardiac death in the Brugada syndrome

Chairpersons: Dobromir Dobrev (Essen, DE), Bo G. Winkel (Copenhagen DK)

1. Pathogenesis of the Brugada syndrome Bo G. Winkel (Copenhagen DK)

2. Pharmacotherapy of Brugada syndromeLena Rivard (Montreal, CA)

3. Indications of implantable cardioverter defibrillator in the Brugada SyndromeDaniel Steven (Cologne, DE)

4. Debate: Catheter ablation plays a role in the Brugada syndrome (30min)

Protagonist: Philippe Chevalier (Lyon, FR)

Antagonist: Riccardo Cappato (Milan, IT)

MONDAY JUNE 17, 20198:30 AM - 10:00 AMROOM MUCEMSession SP-11

Stroke prevention in atrial fibrillation – State of the art

Chairpersons: Andrea Russo (Camden, USA), Ernst Vester (Düsseldorf, DE)

1. Pharmacological stroke preventionHeidi Estner (Munich, DE)

2. Endocardial LAA OcclusionThorsten Lewalter (Munich, DE)

3. Epicardial LAA exclusionLuigi Di Biase (New-York, USA)

12

4. Surgical LAA ClosureSacha Salzberg, (Zurich, CH)

Monday JUNE 17, 2019 12:15PM to 1:45PMRoom EUGENIE

Luncheon PanelBayer

MONDAY JUNE 17, 2019 2:00 PM - 3:30 PMROOM GRAND LARGESession SD-03

First EURA-ECAS Special Session

Sudden death in Hypertrophic Cardiomyopathy (HCM)

Chairpersons: Christine Albert (Boston, USA), Yurij Karpenko (Odessa, Ukraine)

1. Prevention of sudden cardiac death after septal myectomy in HCMMark Estes III (Pittsburgh, USA)

2. ICD for primary prevention of sudden death in hypertrophic cardiomyopathy David Cannom (Los Angeles, USA)

3. Value of electrophysiologic testing in HCMAndrey Ardashev (Moscow, RU)

4. Prevention of stroke in patients with HCM and AFBrian Downey (Boston, USA)

MONDAY JUNE 17, 20192:00 PM - 3:30 PMROOM ESTAQUESession AF-04

Do we need antiarrhythmic drug therapy in the AF ablation era?

Chairpersons: Nils Edvardsson (Goteborg, SE), Alessandro Capucci (Ancona, IT),

1. Antiarrhythmic drugs for termination of recent onset atrial fibrillation Alessandro Capucci (Ancona, IT)

2. Use of antiarrhythmic therapy before and after electrical cardioversion

13

Juan Tamargo (Madrid, ES)

3. Antiarrhythmic therapy for AF in heart failure with preserved ejection fraction (HFpEF)

Samuel Lévy (Marseille, FR)

4. Short-term use of antiarrhythmic drug therapy after catheter ablation (The East-AF Trial)

Kasuaki Kaitani (Tenri, JP)

MONDAY JUNE 17, 20192:00 PM - 3:30 PMROOM JOLIETTESession WS-09A tribute to Arthur Moss, MD In MemoriamICD therapy in 2019: Is it time to alter current device selection criteria Introduction: Arthur Moss, MD A giant in the “Fight against sudden death” (5min)David Cannom (Los Angeles, USA),

Chairpersons: Massimo Santini (Rome, IT), David Cannom (Los Angeles, USA)

1. LV ejection fraction: The legacy of an AVID substudy evolving to present day role in sudden death risk stratification

Sanjeev Saksena (Warren, USA)

2. Biomarkers to identify patients at risk for sudden cardiac death Werner Jung (Villingen, DE)

3. Aging and sudden death risk: do we understand the relationship?Helmut Klein (Cologne, DE)

4. Genetics and risk of sudden death in risk stratification models Stefan Kaab (Munich, DE)

MONDAY JUNE 17, 20192:00 PM - 3:30 PMROOM SAINT JEANSession SP-12

Special Session HRS-ECAS I

Two decades of arrhythmogenic cardiomyopathy (ACM) research: New insights into diagnosis and treatment

Chairpersons: Richard Hauer (Utrecht, NL), Frank Marcus (Tucson, USA)

1. Critical appraisal of the 2010 Task Force criteriaDomenico Corrado (Padua, IT)  

2. Use of auto-antibodies for identification of ACMFirat Duru (Zurich, CH)

14

3. Role of catheter ablation in ACMHugh Calkins (Baltimore, USA)

4. Arrhythmogenic cardiomyopathy: The Chinese experienceJiangping Song (Beijing, China)  

MONDAY JUNE 17, 20192:00 PM - 3:30 PMROOM MUCEMSession SP-13Atrial fibrillation management after pivotal clinical trials: the dilemmas

Chairs: Thorsten Lewalter (Munich, DE), Luc De Roy (Louvain, BE)

1. Should there be changes in the practice guidelines beyond the existing recommendations

John Camm (London, GB)

2. Should all patients with atrial fibrillation and systolic ventricular dysfunction be considered for catheter ablation as first line therapy Ernst Vester (Dusseldorf, DE)

3. Patients with highly symptomatic palpitations regardless of age should be offered AF ablation as first line optionPrapa Kanagaratnam (London, GB)

4. All catheter ablation procedures in AF are created equal as long as they include pulmonary vein isolation

Andrea Natale ( Austin, USA)

MONDAY JUNE 17, 20192:00 PM - 3:30 PMROOM NOTRE DAMESession SP-14

Revisiting cardiac pacing in 2019: New insights into pathophysiology will lead to improved pacing therapies Supported by an educational grant from Bayer AG

Chairs: Jeanne Poole (Seattle, USA ), Luca Santini (Rome, IT)

1. His Bundle pacing : what the past and present teach us about its physiologic effects Robert J. Myerburg (Miami, USA) TBC

2. The clinical role of His Bundle pacing in heart failure with intraventricular conduction defects

15

Pugazhendhi Vijayaraman (Wilkes Barre, USA)

3. Fibrillation prevention and therapy algorithms: Do they belong in all bradycardia and tachycardia devices?

TBA

4. Is it time for mechanical physiologic benefits of multisite pacing modes to be tested in upstream therapy for heart failure and arrhythmia prevention?

Sanjeev Saksena (Warren, USA)

MONDAY JUNE 17, 20192:00 PM - 3:30 PMROOM LACYDONChaired Poster session D

3:30 PM - 4:00 PM Coffee break and visit to posters

MONDAY JUNE 17, 2019 4:00 PM - 5:30 PMROOM GRAND LARGESession SD-04

Management of inherited potentially lethal arrhythmia syndromes

Chairpersons: Xavier Jouven (Paris, FR), Stefan Kaab (Munich, DE)

1. Long QT syndromePeter Schwartz (Milan, IT)

2. Brugada SyndromeXavier Jouven (Paris, FR)

3. Catecholaminergic polymorphic ventricular tachycardiaMichael Eldar (Tel Aviv, IL)

4. Early repolarisation syndrome Stefan Kaab (Munich, DE)

MONDAY JUNE 17, 20194:00 PM - 5:30 PMROOM ESTAQUESession AF-05

Atrial fibrillation meets neurology

Chairpersons: Heidi Estner (Munich, DE), Soeren Z. Diederichsen, (Copenhagen, DK)

16

1. Secondary stroke prevention in embolic stroke of undetermined source (ESUS)– al-ways go for an implanted loop recorder?

Tamas Szili-Torok (Rotterdam, NL)

2. Patent foramen ovale – always go for occlusion?Meier Bernhard (Bern, CH)

3. LAA occluder – always close the ear?Luigi Di Biase (New-York, USA)

4. Atrial High Rate Episodes (AHRE) – always go for anticoagulation?Michael Näbauer (Munich, DE)

MONDAY JUNE 17, 20194:00 PM - 5:30 PM ROOM JOLIETTESession SP-16

Special Session HRS-ECAS IIThe physician’s dilemma: Accurate prediction of sudden death in arrhythmogenic cardiomyopathy (ACM)

Chairpersons: Hugh Calkins (Baltimore, USA), Richard Hauer (Utrecht, NL)

1. Use of advanced imaging techniques in arrhythmic risk stratification of ACMAnneline te Riele (Utrecht, NL)

2. Towards personalized risk assessment in ACMCindy James (Baltimore, USA)  

3. Debate: Can ACM lead to sudden death in a structurally normal heart?

Protagonist : Mario Delmar (New York, USA) Antagonist: Cristina Basso (Padua, IT)  

MONDAY JUNE 17, 20194:00 PM - 5:30 PMROOM SAINT JEANSession SP-17

Personalized medicine and AF: will it ever happens?Supported by an educational grant from Bayer AG

Chairpersons: Leonardo Calò (Rome, IT), Mark Estes III (Pittsburg, USA)

1. In the context of 2 decades of progress do we need a new AF classification?

Samuel Levy (Marseille, FR)

17

2. AF MechanismsDobromir Dobrev (Essen, DE)

3. Rhythm controlAndrea Natale (Austin, USA)

4. Stroke preventionRiccardo Cappato (Milan, IT)

MONDAY JUNE 17, 20194:00 PM - 5:30 PMROOM MUCEMSession WS-08

ECG interpretation course (Part 2): Complex arrhythmias (Case-studies)A tribute to Ralph Lazzara In MemoriamIntroduction: Warren Jackman (Oklahoma City, USA) (5min)

Chairpersons: John Camm (London, GB), Jean-Jacques Blanc (Brest, FR)

1. Differential diagnosis of narrow QRS complex tachycardiasWarren Jackman (Oklahoma City, USA)

2. Differential diagnosis of wide QRS complex tachycardiasRobert Frank (Paris, FR)TBC

3. Tachycardias in the preexcitation syndromesLeonardo Calo (Rome, IT)

MONDAY JUNE 17, 2019 5:30 PM - 6:15 PMROOM GRAND LARGEDebate 1

First PV Isolation should be performed with a cryoballoon

Chairpersons: Edward Rowland (London, GB), Ellen Hoffmann (Munich, DE)

Protagonist: Karl-Heinz Kuck (Hamburg, DE)

Antagonist: Dipen Shah (Geneva, CH)

MONDAY JUNE 17, 20195:30 PM - 6:15 PMROOM JOLIETTEDebate 2

18

Non-pharmacologic therapy has no role in heart failure with preserved ejection fraction

Chairs: John A. Camm (London, GB), Habib Haouala (Tunis, TN)

Protagonist: Christian Torp-Pedersen (Copenhagen, DK)

Antagonist: Sanjeev Saksena (Warren, USA)

MONDAY JUNE 17, 20195:30 PM - 6:15 PMROOM MUCEMDebate 3

Sudden death prophylaxis in nonischemic cardiomyopathy: The role of implantable defibrillators should be removed from the guidelines

Chairs: Niraj Varma (Cleveland, USA), Helmut Klein (Munich, DE)

Protagonist: Jean-Jacques Blanc (Brest, France)

Antagonist: Bruce Wilkoff (Cleveland, USA)

MONDAY JUNE 17, 20195:30 PM - 6:15 PMROOM DEBARCADAIRE GRAND LARGE ?? ou SAINT JEAN ???Debate 4

PVI should be 1st line therapy in all symptomatic AF patients

Chairpersons: Riccardo Cappato (Milan, IT), Gilles Lascault (Paris, FR) Protagonist: Walid Saliba (Cleveland, USA)

Antagonist: Mark Estes III (Pittsburg, USA)

MONDAY JUNE 17, 20196:15PM-7:00PM ROOM ??

Special Lecture: Mark Josephson, MD In Memoriam

TUESDAY JUNE 18, 201910:30 AM - 12:00 PM ROOM GRAND LARGESession SP-19

Pacing management of bradyarrhythmias - Beyond the Guidelines

19

Chairpersons: David G Benditt (Minneapolis, USA), Luca Santini (Rome, IT)

1. Can carotid sinus hypersensitivity ever be an indication for pacing?Steve Parry (Newcastle, GB)

2. Mobitz type 1 block in the elderly: A possible pacing Indication?Richard Sutton (Monaco, MC)

3. When is pacing appropriate in vasovagal syncope? Brian Olshansky (Iowa City, USA)

4. Leadless cardiac pacemakers for bradyarrhythmias Werner Jung (Villingen, DE)

TUESDAY JUNE 18, 201910:30 AM - 12:00 PMROOM ESTAQUESession SP-20

New tools and mapping for ablation

Chairpersons: Daniel Steven (Cologne, DE), Shlomo Ben-Haim (London-GB)TBC

1. High-Power Short-duration for AF ablation Roger Winkle (Palo Alto, USA)

2. Dipole density mapping (ACUTUS™) in persistent AF Tom Wong (London GB)

3. Real-time Local Impedance Measurement Reza Wakili (Essen, DE)

4. Real-time wide band di-electric sensing system (KODEX-EPD™) Evgeny Pokushalov (Novosibirsk, RU)TBC

TUESDAY JUNE 18, 201910:30 AM - 12:00 PMROOM JOLIETTESession SP-21Mapping and ablation of scar related VT

Chairs: David Wilber (Chicago, USA), Eugene Crystal (Toronto, CA)TBC

1. High- density Mapping improves outcomes of VT ablationMohammad Shenasa (San José, USA)

2. Substrate imaging is mandatory in scar related VT ablationElena Ene (Bad Neustadt, DE)

3. Substrate homogenization: All you can reach

20

Jose Merino (Madrid, ES)

4. Are the guidelines on VT ablation still adequate?John Camm (London, GB)

TUESDAY JUNE 18, 201910:30 AM - 12:00 PMROOM SAINT JEANSession SP-22Non-Pharmacological management of heart failure: What is new?

Chairpersons: Nicholas Peters (London, GB), Erik Bloch-Thomsen (Copenhagen, DK)

1. What’s new in patient selection for heart failure devices? TBA

2. What’s new in LV electrodes and their placement ? Francesco Zanon (Rovigo, IT)

1. What’s new in heart failure device programming to optimize function, at implant, post implant and beat-to-beat?Robert Hauser (Minneapolis, USA)

2. Cardiac contractility modulation (CCM) therapy:  Does it work? How does it work?   Where does it fit with other heart failure device manage-ment?Neil Sulke (Eastbourne, GB)

TUESDAY JUNE 18, 201910:30 AM - 12:00 PMROOM MUCEMSession SP-23

Atrial fibrillation: emerging risk factors

Chairs: Alessandro Capucci (Ancona, IT), Luis Molina (Mexico City, MX)

4. ObesityPromound Obel (Johannesburg, ZA)

5. Obstructive sleep apnea syndromeAdam S Fein (Boston, USA)TBC

6. Physical activityFrancesco Furlanello (Milan, IT)

7. Food and antioxidationLeonardo Calò (Rome, IT)

21

12:00 PM - 12:30 PM BEST POSTER AWARDS